| Pharmaceutical strategies for the topical dermal delivery of peptides/proteins for cosmetic and therapeutic applications T Badenhorst, D Svirskis, Z Wu Austin J. Pharmacol. Ther 2, 1-10, 2014 | 29 | 2014 |
| Type 2 diabetes mellitus and metformin hydrochloride usage: a short GF Petrovick J Pharmacol 2 (2), 5, 2018 | 12 | 2018 |
| Advance measures and challenges of wound healing M Sinha J Pharmacol Ther Res 2 (1), 1-3, 2018 | 11 | 2018 |
| Vericiguat in combination with short‐acting nitroglycerin in patients with chronic coronary syndromes: the randomized, phase Ib, VENICE study M Boettcher, HD Düngen, F Donath, G Mikus, N Werner, PA Thuermann, ... Clinical Pharmacology & Therapeutics 111 (6), 1239-1247, 2022 | 7 | 2022 |
| Is taurine a pharmaconutrient RC Guta J. Pharmacol. Ther. Res 2, 18-20, 2018 | 6 | 2018 |
| Dengue and doxycycline-experience in a tertiary care hospital in eastern India in the year 2017-An initial report B Bhattacharjee, S Bhattacharya, B Sardar, P Raj, M Ghosh, D Majumdar, ... J Pharmacol Ther Res 2 (2), 14-17, 2018 | 4 | 2018 |
| Synthesis, Design and Anti-inflammatory Activity of Novel 5-(Indol-3-yl) thiazolidinone Derivatives as COX-2 Inhibitors SR Atta-Allah, NSM Ismail, IF Nassar Letters in Drug Design & Discovery 18 (6), 525-541, 2021 | 3 | 2021 |
| Promote healing and anti-inflammatory and anti-bacterial activities of Jinjianling cream W Zhao, MY Qiu, CX Ma, PH Gong, YT Liu, MM Yan, S Shao, DQ Zhao J. Pharmacol. Thera Res, 2018 | 2 | 2018 |
| Use of drugs in Argentina: A worrying issue E Rodriguez J Pharmacol Ther Res 2 (1), 6-8, 2018 | 2 | 2018 |
| Assessment of amino acid in hypertensive patients Y Khider J Pharmacol Ther Res 2018; 2 (3): 3-5. 4 J Pharmacol Ther Res 2018 Volume 2 …, 2018 | 1 | 2018 |
| Clinical preliminary variety: A chance for further developed knowledge into the determinants of fluctuation in drug reaction. D Pasqua* Journal of Pharmacology and Therapeutic Research 7 (1), 1-2, 2023 | | 2023 |
| Exosome Delivery and Low pH have a place with a System of Obstruction of Human Melanoma Cells to Cisplatin N Violante* Journal of Pharmacology and Therapeutic Research 7 (2), 1-2, 2023 | | 2023 |
| The significance of direct tolerant detailing of unfavorable medication responses in the wellbeing observing cycle. J Sienkiewicz* Journal of Pharmacology and Therapeutic Research 6 (6), 1-2, 2022 | | 2022 |
| Objective pee medication checking in patients getting narcotics for constant torment: Agreement suggestions. D Alford* Journal of Pharmacology and Therapeutic Research 6 (6), 1-2, 2022 | | 2022 |
| Helpful medication observing in youngsters and teenagers with schizophrenia and maniacal issues. P Wiedenhoff* Journal of Pharmacology and Therapeutic Research 6 (6), 1-2, 2022 | | 2022 |
| Metabolomic marks for medication reaction aggregates: Pharmacometabolomics empowers accuracy medication. R Kaddurah-Daouk* Journal of Pharmacology and Therapeutic Research 6 (5), 1-2, 2022 | | 2022 |
| The impacts of phosphodiesterase inhibitors on growth rot factor-α and leukotriene B4 in human. C Brideau* Journal of Pharmacology and Therapeutic Research 6 (5), 1-2, 2022 | | 2022 |
| Mouse models for safe designated spot bar restorative exploration in oral malignant growth. M Noteborn* Journal of Pharmacology and Therapeutic Research 6 (5), 1-2, 2022 | | 2022 |
| Metabolomic marks for medication reaction aggregates: Pharmacometabolomics empowers accuracy medication. R Kaddurah-Daouk Journal of Pharmacology and Therapeutic Research 6 (5), 1-2, 2022 | | 2022 |
| Mouse models for safe designated spot bar restorative exploration in oral malignant growth. M Noteborn* Journal of Pharmacology and Therapeutic Research 6 (5), 1-2, 2022 | | 2022 |
Darren SvirskisUniveristy of AucklandVerified email at auckland.ac.nz
